TADALAFIL
- Product NDC
- 48792-7890
- 11-digit product format
- 487927890
- Labeler code
- 48792
- Product ID
- 48792-7890_85105eb5-3e71-5d37-e053-2a91aa0a3ea8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tadalafil
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Sunshine Lake Pharma Co., Ltd.
- Application
- ANDA211335
- Marketing category
- ANDA
- Marketing start
- 2019-03-27
- Marketing end
- 0000-00-00
- Substance
- TADALAFIL
- Active strength
- 20 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 48792-7890-1 | 48792789001 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (48792-7890-1) | 2019-03-27 | 0000-00-00 | No | No | Current |
| 48792-7890-2 | 48792789002 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (48792-7890-2) | 2019-03-27 | 0000-00-00 | No | No | Current |